| 臺大學術典藏 |
2021-05-25T06:36:19Z |
Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan
|
Tien H.-F.; Chuang S.-M.; Wang C.-H.; Lee F.-Y.; Chien S.-H.; Chen Y.-C.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:19Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
Cheng A.-L.; Chen Y.-C.; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; Lai H.-S.; Liu T.-W.; Tien H.-F.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:19Z |
Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens
|
Lin M.-T.; Chen Y.-C.; Liu T.-W.; Tien H.-F.; Liu M.-C.; Wang C.-H.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:18Z |
Immunoglobulin and T-cell receptor gene rearrangements in acute lymphoblastic leukemia-A higher incidence of double rearrangements in patients with myeloid antigen expression
|
Tien H.-F.; Wang C.-H.; Su I.-J.; Wu H.-S.; Chien S.-H.; Chen Y.-C.; Lin D.-T.; Lin K.-H.; MING-CHING SHEN |
| 臺大學術典藏 |
2021-05-25T06:36:18Z |
A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7- morphologic, cytochemical, immunocytochemical and t cell receptor gene analysis on 13 patients
|
Tien H.-F.; Wang C.-H.; Su I.-J.; Liu F.-S.; Wu H.-S.; Chen Y.-C.; Lin K.-H.; Lee S.-C.; MING-CHING SHEN |
| 臺大學術典藏 |
2021-05-25T06:36:18Z |
Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease
|
Tien H.F.; Wang C.H.; Chen Y.C.; MING-CHING SHEN; Wu H.S.; Lee F.Y.; Chuang S.M.; Liu C.H. |
| 臺大學術典藏 |
2021-05-25T06:36:17Z |
Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis
|
Tien H.-F.; Wang C.-H.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; Chen Y.C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H.; Lin K.-S.; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:17Z |
PERIPHERAL Tγ/δ LYMPHOMA PRESENTING WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA?LIKE PICTURE
|
Lin M.?T.; MING-CHING SHEN; Su I.?J.; Tien H.?F.; Chen Y.?C.; Hsu P.?N.; Chang C.?S.; Wang C.?H. |
| 臺大學術典藏 |
2021-05-25T06:36:17Z |
A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
|
Hsu P.N.; Tien H.F.; Wang C.H.; Chen Y.C.; MING-CHING SHEN; Lin D.T.; Lin K.H.; Liang D.C.; Lin K.S. |
| 臺大學術典藏 |
2021-05-25T06:36:16Z |
Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
|
Ch'ang H.-J.; Tien H.-F.; Wang C.-H.; Chuang S.-M.; Chen Y.C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:16Z |
Cytogenetic study of acute lymphoblastic leukemia and its correlation with immunophenotype and genotype
|
Tien H.-F.; Wang C.-H.; Lee F.-Y.; Liu M.-C.; Chuang S.-M.; Chen Y.-C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H.; Chuu W.-M. |
| 臺大學術典藏 |
2021-05-25T06:36:15Z |
Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: Different biologic features between T-cell antigen positive and B-cell antigen positive AML
|
Tien H.-F.; Wang C.-H.; Chen Y.C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:14Z |
Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan
|
Tien H.-F.; Wang C.-H.; Chuang S.-M.; Chow J.-M.; Lee F.-Y.; Liu M.-C.; Chen Y.-C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:14Z |
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study
|
Cheng A.-L.; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; Pu Y.-S.; Hong R.-L.; MING-CHING SHEN; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-25T06:36:13Z |
Acute leukemic transformation of myelodysplastic syndrome-Immunophenotypic, genotypic, and cytogenetic studies
|
Tien H.-F.; Wang C.-H.; Chuang S.-M.; Lee F.-Y.; Liu M.-C.; Chen Y.-C.; MING-CHING SHEN; Lin K.-H.; Lin D.-T. |
| 臺大學術典藏 |
2021-05-25T06:36:12Z |
Consistent presence of isochromosome 7q in hepatosplenic t γ/δ lymphoma: A new cytogenetic?clinicopathologic entity
|
Wang C.?C.; Tien H.?F.; Lin M.?T.; Su I.?J.; Wang C.?H.; Chuang S.?M.; MING-CHING SHEN; Liu C.?H. |
| 臺大學術典藏 |
2021-05-25T06:36:11Z |
Clinical and hematological characteristics of hepatosplenic T γ/δ lymphoma with isochromosome for long arm of chromosome 7
|
Yao M.; Tien H.-F.; Lin M.-T.; Su I.-J.; Wang C.-T.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:11Z |
Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia A study of 235 Chinese patients in Taiwan
|
Tien H.-F.; Wang C.-H.; Lin M.-T.; Lee F.-Y.; Liu M.-C.; Chuang S.-M.; Chen Y.-C.; MING-CHING SHEN; Lin K.-H.; Lin D.-T. |
| 臺大學術典藏 |
2021-05-25T06:36:10Z |
Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas
|
Yeh K.-H.; Cheng A.-L.; Su I.H.-J.; Lin M.-T.; Tien H.-F.; MING-CHING SHEN; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-25T06:36:10Z |
Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans-retinoic acid treatment
|
Chou W.-C.; Tang J.-L.; Yao M.; Liang Y.-J.; Lee F.-Y.; Lin M.-T.; Wang C.-H.; MING-CHING SHEN; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:07Z |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
|
Huang S.-Y.I.; Chang C.-S.; Tang J.-L.; Tien H.-F.; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; Chou W.-C.; Chung C.-Y.; Wang C.-H.; MING-CHING SHEN; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-25T06:36:07Z |
Clonal disease of natural killer large granular lymphocytes in Taiwan
|
Chou W.-C.; Chiang I.-P.; Tang J.-L.; Su I.-J.; Huang S.-Y.I.; Chen Y.-C.; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; MING-CHING SHEN; Chuang S.-M.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:06Z |
Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factor
|
Ko B.-S.; Tang J.-L.; Chen Y.-C.; Yao M.; Wang C.-H.; MING-CHING SHEN; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:06Z |
Minimally differentiated acute myeloid leukemia in Taiwan: Predominantly occurs in children less than 3 years and adults between 51 and 70 years
|
Huang S.-Y.; Tang J.-L.; Jou S.-T.; Tsay W.; Hu C.-H.; Lin D.-T.; Lin K.-S.; Lin K.-S.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:05Z |
Characterization of acute myeloid leukemia with MLL rearrangements - No increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts
|
Tien H.-F.; Hsiao C.-H.; Tang J.-L.; Tsay W.; Hu C.-H.; Kuo Y.-Y.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H.; Lin K.-S. |
| 臺大學術典藏 |
2021-05-25T06:36:03Z |
Methylation of the p15INK4B gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation
|
Tien H.-F.; Tang J.-L.; Tsay W.; Liu M.-C.; Lee F.-Y.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN |
| 臺大學術典藏 |
2021-05-25T06:36:02Z |
High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan
|
Hsiao C.-H.; Tang J.L.; Yao M.; Tsay W.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:01Z |
SOCSI methylation in patients with newly diagnosed acute myeloid leukemia
|
Chen C.-Y.; Tsay W.; Tang J.-L.; Shen H.-L.; Lin S.-W.; Huang S.-Y.; Yao M.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:01Z |
Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: Incidence, treatment, and prognosis
|
Chen C.-Y.; Chen Y.-C.; Tang J.-L.; Yao M.; Huang S.-Y.; Tsai W.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:36:00Z |
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
|
Huang S.-Y.; Tang J.-L.; Yao M.; Ko B.-S.; Hong R.-L.; Tsai W.; Wang C.-H.; Tien H.-F.; MING-CHING SHEN; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-25T06:35:59Z |
Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan
|
Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Lee F.-Y.; Liu M.-C.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:35:59Z |
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy
|
Chen C.-Y.; Tang J.-L.; Hsueh P.-R.; Yao M.; Huang S.-Y.; Chen Y.-C.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Tsai W.; Chang S.-C.; Tien H.-F.; Luh K.-T. |
| 臺大學術典藏 |
2021-05-25T06:35:58Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.; Yao M.; Chou W.-C.; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:35:57Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:35:57Z |
Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years
|
Huang S.-Y.; Yao M.; Tang J.-L.; Lee W.-C.; Tsay W.; Cheng A.-L.; Wang C.-H.; Chen Y.-C.; MING-CHING SHEN; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:28Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:27Z |
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
|
Tang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:27Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; Chou W.-C.; SZU-CHUN HSU; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-05-19T01:57:26Z |
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
|
Chou W.-C.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:25Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:24Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:24Z |
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
|
Chou W.-C.; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:23Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Cheng C.-L.; Hou H.-A.; Jhuang J.-Y.; Lin C.-W.; Chen C.-Y.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:23Z |
Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever
|
Lin C.-H.; Yao M.; SZU-CHUN HSU; Ho C.-C.; Lin M.-T.; Lin C.-A.; Hu F.-C.; Yu C.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:22Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:22Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:21Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:20Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; SZU-CHUN HSU; Ko B.-S.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:20Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; Ko B.-S.; Chen C.-Y.; SZU-CHUN HSU; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-19T01:57:19Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
